Biovitrum

January 2009

BUYER

Biovitrum is a Swedish pharmceutical company formed in 2001 as a spin-out from Pfizer. Biovitrum had sales in 2009 of SEK 1,3 bn.

TARGET

Swedish Orphan International is a private Swedish pharmaceutical company with specialist products within rare diseases. SOI had sales in 2009 of SEK 0,7 bn.

SELLER

SOI was owned by Investor Growth Capital – a part of the listed investment company Investor AB, and Priveq – a Swedish small cap private Equity investor.

TRANSACTION

SOI was sold in a structured auction process with strong interest from industrial and financial buyers.